🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical study will assess the safety, reactogenicity and immunogenici...
Status
Completed
Location
Research Centers of America
Start Date
2017-11-13
Trial ID
NCT03382405
The main objective of this study is to evaluate the safety, reactogenicity,...
Status
Completed
Location
Velocity Clinical Research
Start Date
2021-11-08
Trial ID
NCT05105048
The main purpose of the study is to evaluate the efficacy and safety of mRN...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2023-04-05
Trial ID
NCT05683457
The main purpose of the extension phase of this study is to evaluate the lo...
Status
Completed
Location
Optimal Research, LLC
Start Date
2021-06-18
Trial ID
NCT04975893
The purpose of this research study is to test the safety and tolerability o...
Status
Completed
Location
Virginia Commonwealth University
Start Date
2010-09
Trial ID
NCT01195571
Treatments Being Tested
Treatment strategy of patients: Stem cell engraftment (myeloablative or NS...
Status
Withdrawn
Location
Hadassah Medical Organization
Start Date
2004-02
Trial ID
NCT00159055
Treatments Being Tested
The main goal of this study is to evaluate the safety, reactogenicity, and ...
Status
Completed
Location
CenExel
Start Date
2022-05-24
Trial ID
NCT05397223
The main purpose of this study is to evaluate the efficacy of mRNA 1647 vac...
Status
Terminated
Location
Central Research Associates Inc
Start Date
2021-10-26
Trial ID
NCT05085366
The purpose of this study is to assess the effect of pre-transplant mRNA-16...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-02-08
Trial ID
NCT06133010
The main purpose of study is to evaluate the safety and immunogenicity of d...
Status
Completed
Location
Paradigm Clinical Research Institute Inc - ClinEdge - PPDS
Start Date
2022-11-07
Trial ID
NCT05575492